tiprankstipranks
Advertisement
Advertisement

TLSA Stock Latest News

Tiziana Life Sciences Reports Positive Preclinical Data for Nasal Anti-CD3 in Age-Related Cognitive Decline
Company AnnouncementsTiziana Life Sciences Reports Positive Preclinical Data for Nasal Anti-CD3 in Age-Related Cognitive Decline
19h ago
6K
TLSA
Tiziana Life Sciences Posts Positive Biomarker Data for Intranasal Foralumab in Progressive MS
PremiumCompany Announcements
Tiziana Life Sciences Posts Positive Biomarker Data for Intranasal Foralumab in Progressive MS
1M ago
6K
TLSA
Tiziana Life Sciences announces new data on nasal foralumab
PremiumThe Fly
Tiziana Life Sciences announces new data on nasal foralumab
1M ago
TLSA
Tiziana Life Sciences’ Intranasal Foralumab MS Study Published in Leading Neurology Journal
PremiumCompany Announcements
Tiziana Life Sciences’ Intranasal Foralumab MS Study Published in Leading Neurology Journal
2M ago
6K
TLSA
Tiziana Life Sciences announces publication of intranasal foralumab results
PremiumThe Fly
Tiziana Life Sciences announces publication of intranasal foralumab results
2M ago
TLSA
Tiziana Life Sciences Raises $8.8 Million in Oversubscribed Direct Offering to Fund Phase 2 Trials
PremiumCompany AnnouncementsTiziana Life Sciences Raises $8.8 Million in Oversubscribed Direct Offering to Fund Phase 2 Trials
3M ago
6K
TLSA
Tiziana Life Sciences Raises Up to $17.6 Million in Insider-Led Direct Offering to Fund Phase 2 Trials
Premium
Company Announcements
Tiziana Life Sciences Raises Up to $17.6 Million in Insider-Led Direct Offering to Fund Phase 2 Trials
3M ago
6K
TLSA
Tiziana Life Sciences prices 6.4M shares at $1.25 in registered direct offering
Premium
The Fly
Tiziana Life Sciences prices 6.4M shares at $1.25 in registered direct offering
3M ago
TLSA
Tiziana Life Sciences to Showcase Intranasal Foralumab at Neuroscience Innovation Forum During JPM Week
PremiumCompany Announcements
Tiziana Life Sciences to Showcase Intranasal Foralumab at Neuroscience Innovation Forum During JPM Week
3M ago
6K
TLSA
Tiziana Reports Clean FDA Safety Update for Intranasal Foralumab After 37.4 Patient-Years of Exposure
PremiumCompany Announcements
Tiziana Reports Clean FDA Safety Update for Intranasal Foralumab After 37.4 Patient-Years of Exposure
3M ago
6K
TLSA
Tiziana Life Sciences files annual safety report for intranasal foralumab
PremiumThe Fly
Tiziana Life Sciences files annual safety report for intranasal foralumab
3M ago
TLSA
Tiziana Life Sciences Chair Boosts Stake to 36% with December Share Purchase
PremiumCompany Announcements
Tiziana Life Sciences Chair Boosts Stake to 36% with December Share Purchase
3M ago
6K
TLSA
Tiziana Life Sciences Chairman raises stake to 36% with acquisition of shares
PremiumThe FlyTiziana Life Sciences Chairman raises stake to 36% with acquisition of shares
3M ago
TLSA
Tiziana Life Sciences Rings Nasdaq Closing Bell Celebrating Milestone in Biotechnology
Premium
Company Announcements
Tiziana Life Sciences Rings Nasdaq Closing Bell Celebrating Milestone in Biotechnology
4M ago
6K
TLSA
Tiziana Life Sciences Doses First Patient in Critical Phase 2 Alzheimer’s Trial
Premium
Company Announcements
Tiziana Life Sciences Doses First Patient in Critical Phase 2 Alzheimer’s Trial
4M ago
6K
TLSA
Tiziana Life Sciences doses first patient in Phase 2 Alzheimer’s trial
PremiumThe Fly
Tiziana Life Sciences doses first patient in Phase 2 Alzheimer’s trial
4M ago
TLSA
Tiziana Life Sciences CEO Increases Stake with Significant Share Purchase
PremiumCompany Announcements
Tiziana Life Sciences CEO Increases Stake with Significant Share Purchase
4M ago
6K
TLSA
Tiziana Life Sciences CEO Ivor Elrifi purchases 163,400 shares
PremiumThe Fly
Tiziana Life Sciences CEO Ivor Elrifi purchases 163,400 shares
4M ago
TLSA
Tiziana Life Sciences Withdraws Public Offering Amid Market Conditions
PremiumCompany Announcements
Tiziana Life Sciences Withdraws Public Offering Amid Market Conditions
4M ago
6K
TLSA
Tiziana Life Sciences announces withdrawal of proposed public offering
PremiumThe FlyTiziana Life Sciences announces withdrawal of proposed public offering
4M ago
TLSA
Tiziana Life Sciences Initiates Phase 2 Alzheimer’s Trial with Innovative Approach
Premium
Company Announcements
Tiziana Life Sciences Initiates Phase 2 Alzheimer’s Trial with Innovative Approach
4M ago
6K
TLSA
Tiziana Life Sciences to dose first patient in Phase 2 Alzheimer’s trial
Premium
The Fly
Tiziana Life Sciences to dose first patient in Phase 2 Alzheimer’s trial
4M ago
TLSA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >